{"id":"W2991954549","doi":"10.2147/jaa.s227170","title":"<p>Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma</p>","year":2019,"lang":"en","type":"article","venue":"Journal of Asthma and Allergy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital","funders":"Pearl Therapeutics; Genentech; Sunovion; AstraZeneca; Chiesi Farmaceutici; CSL Behring; Mylan; GlaxoSmithKline; Biogen; Sanofi; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; American Thoracic Society","keywords":"Benralizumab; Medicine; Exacerbation; Asthma; Eosinophil; Internal medicine; Mepolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004889573,0.0005241935,0.0009272431,0.0004166635,0.0002200039,0.0006866012,0.0004465381,0.0006429061,0.001047841],"category_scores_gemma":[0.001880735,0.000307807,0.001390936,0.0003342681,0.0004097164,0.0004896309,0.0004286011,0.001186649,0.0002606217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001073211,"about_ca_system_score_gemma":0.001122759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009062099,"about_ca_topic_score_gemma":0.001064256,"domain_scores_codex":[0.9986135,0.0005495653,0.00008539067,0.0002494233,0.0003060344,0.0001960507],"domain_scores_gemma":[0.9970551,0.0004147013,0.001344662,0.0002284875,0.0003281809,0.0006289255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5807452,0.0157951,0.2009551,0.0009826826,0.005555128,0.0005657563,0.0003157702,0.006031933,0.05015473,0.000287304,0.00315926,0.1354522],"study_design_scores_gemma":[0.05486234,0.3490042,0.5740554,0.00007918692,0.003692814,0.0008120952,0.00007289769,0.005194155,0.008248858,0.000168697,0.003730579,0.0000787309],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969312,0.001201808,0.0003878849,0.0000900179,0.0000137399,0.0002655371,0.0005553418,0.00001876496,0.0005355999],"genre_scores_gemma":[0.9978005,0.0002238449,0.0002848118,0.0001460309,0.00003836806,0.0001495683,0.001011587,0.000004237322,0.0003408673],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004889573,"threshold_uncertainty_score":0.02585888,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006554322464625234,"score_gpt":0.2462140875855967,"score_spread":0.2396597651209715,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}